An internal biomérieux investigation was initiated due to a false susceptible vancomycin (va) result associated with the vitek® 2 (v7.01) ast-p586 cards invovling an enterococcus faecium.The reference method (broth microdilution, bmd), which was the method used for vancomycin development (formulation va04n) on vitek 2 ast-p586, gave: bmd va mic > 64 mg/l r.On vitek 2 v7.01 (aes parameters : eucast + phenotypic), four (4) ast-p586 cards (one from the customer lot n°1, cl1 3660564203, one from the customer lot n°2, cl2 3660477403, one from the customer lot n°3, cl3 3660600403, and one from a random lot rl 3660410203) were tested.Cl1/cl2/cl3: va mic = 8 mg/l r with "van b like" phenotype.Rl: va mic <= 0.5 mg/l s with "wild" phenotype.The mic values on cl1, 2 and 3 were an essential agreement error compared to the reference result without category error.The false susceptible vancomycin on vitek 2 was reproduced on the rl (<=0.5 mg/l).This result is an essential agreement error comparing to the reference result leading to a very major category error.The underestimation of vancomycin on the vitek 2 ast-p586 card was confirmed in-house.This underestimation can lead to a non-detection of the van b like phenotype on rl only.A complaint and trend review were performed.No action was determined to be necessary at this time.
|